Skip to content
★ Sign in to follow
WR

William R. Ringo

Board Director
Director
Faeth Therapeutics, Inc.Five Prime Therapeutics IncAssembly Biosciences, Inc.Dermira, Inc.Sangamo Therapeutics, IncIntermune IncAbgenix IncPfizer Inc
Total declarations
121
Companies
9
▲ Purchases (0 ops.)
—
▼ Sales (48 ops.)
€4.0M

Latest filing published 12 Jul 2023 for Faeth Therapeutics, Inc..

Filing timeline

BuySale
William R. Ringo

Insider track record

Disclosed buys
0
Disclosed sells
48
Signal history

William R. Ringo: trading record in brief

William R. Ringo, listed as board member, has filed trades across 9 companies (mainly through SEC (Form 4)), most often in Five Prime Therapeutics Inc, Assembly Biosciences, Inc. and Dermira, Inc. We count 121 filings; the first trade dates from 23 February 2006 and the latest from 10 July 2023.

The open-market record consists of 48 sales worth €4.0M, with no purchase. The rest of the record consists of 13 share grants and 51 option exercises.

The latest filing, published on 12 July 2023, reports a share grant in Faeth Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to William R. Ringo

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations120 total

25 of 120 declarations